DKEClass II
Reagents, Test, Tetrahydrocannabinol
21 CFR 862.3870 / Clinical Toxicology
DKE is the FDA product code for Reagents, Test, Tetrahydrocannabinol, a class II device type, regulated under 21 CFR 862.3870. As of , FDA records hold 12 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DKE
- Device name
- Reagents, Test, Tetrahydrocannabinol
- Regulation
- 21 CFR 862.3870
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 12
- Ingested recalls
- 0
Clearances, product code DKE
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1980 | 1 |
| 1983 | 1 |
| 1984 | 1 |
| 1988 | 1 |
| 1990 | 1 |
| 1998 | 2 |
| 1999 | 3 |
| 2000 | 2 |
Applicants with the most clearances
Product code DKE| Applicant | Clearances |
|---|---|
| Princeton BioMeditech Corp. | 4 |
| Marion Laboratories, Inc. | 2 |
| MEDTOX Diagnostics, Inc. | 2 |
| Alfa Scientific Designs, Inc. | 1 |
| Biochemical Diagnostic, Inc. | 1 |
| California Medical Developments, Inc. | 1 |
| Toxi-Lab, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
